Mlm Nutrition Supplements information, tips and advice

Nu Skin International, Inc., of Provo, Utah, sells body-care products and dietary supplements. Nu Skin's Interior Design division markets expensive antioxidant, phytochemical, and "active enzyme" products, in 1993, the company and three of its distributors agreed to pay a total of $1,225,000 to settle FTC charges that they made unsubstantiated claims for Nutriol Hair Fitness Preparation and two skin-care products. In 1997, the company agreed to pay $ million to settle charges that it had made unsubstantiated claims for five more of its products. The products, which contained chromium picolinate and L-carnitine, were falsely claimed to reduce fat, increase metabolism, and preserve or build muscle.

Morinda, Inc., of Linden, Utah, has alleged that its Tahitian Noni juice can treat, cure, or prevent numerous diseases, including diabetes, depression, hemorrhoids, and arthritis. In 1998, the attorneys general of Arizona, California, New Jersey, and Texas announced a settlement under which the company would no longer make disease-related claims that are unsubstantiated or lack FDA approval. The agreement also called for consumer refunds and payment of $100,000 for investigative costs.

In 1998, the FDA ordered Reliv International, Inc., of Chesterfield, Missouri, to stop making unsubstantiated claims that its Arthaffect is effective against degenerative joint conditions.

In 1998, New Vision International, Inc., of Scottsdale, Arizona, and a leading distributor agreed to settle FTC charges that they made unsubstantiated claims in their advertisements for a dietary supplement combination called "God's Recipe." Ads for the recipe had claimed that it could cure Attention Deficit Disorder (ADD) or Attention Deficit Hyperactivity Disorder (ADHD).

Quest IV Health Products, of Arlington, Texas, has claimed that its Restores+ is effective against ADD, ADHD, and specific symptoms related to these diseases, The company also marketed Caucasicum+ as a treatment for alcoholism and heart disease. In 1999, the Texas attorney general secured a consent agreement under which the company was required to pay $15,000 and to stop claiming that the products are effective against these conditions or against any other disease.